(…) UNODC: Thank you, Mr. Chair, distinguished delegates, ladies and gentlemen. It is my pleasure to brief the Commission on some of the significant efforts UNODC has undertaken over the last year to confront the global drug problem, in line with the Ministerial Declaration of 2019. Given time constraints, I will highlight just a few …
Morocco
Item 3. High-level segment (Friday afternoon)
Bangladesh: H. E. Ambassador Johnson, Chair of the Commission on Narcotic Drugs at its 67th Session, H. E. Ghada Waly, Executive Director of the UNODC, Excellencies, Distinguished delegates, Ladies and Gentlemen, Good afternoon. I begin by congratulating Ambassador Johnson and other members of the bureau and assure them of our full support. Mr. Chair, We …
Round Table 2 – The Way Forward: The Road to 2029
Germany/Chair: Hello, welcome to our discussion regarding the way forward in advancing the implementation of all international drug policy commitments in light of the 2029 finally view of certain 2019 Ministerial Declaration in accordance with CND Resolution 66 Adopted by the Commission last March, this roundtable will consist of panel interventions followed by an interactive …
Round Table – Taking Stock: Work Undertaken Since 2019
UN Web TV recording ;Bangladesh/Chair: Discuss the work done around the globe to implement drug control commitments – identify progress, identify challenges. This will consist of a panel of interventions followed by interactive discussions. Mexico/Co-Chair: Delegations wishing to take the floor can raise their panels to nominate themselves. Please bear with me if I call …
2023 CND & CCPCJ Reconvened Session
Secretariat: Distinguished delegates, ladies and gentlemen, As many of you are aware, the term of Her Excellency Ambassador (…), who served as the chair of the CCPCJ 32nd session, concluded at the onset of this conference. On 17 November, the Secretariat received a note from the chair of the African region nominating His Excellency, the Ambassador …
CND Thematic Discussion / Session 11 – Low availability of internationally controlled substances for medical & scientific purposes
Chair: Good Morning. Yesterday we had a fruitful discussion on the issues of the consequences and risk associated with non medical use of drugs. Today we will be discussing the low availability of nationally controlled substances for medical and scientific purposes, including for the relief of pain and palliative care. Before we start a discussion, …